Catalyst Event
Vertex Pharmaceuticals Inc (VRTX) · Earnings Release
From KEDI U.S. Quality500 + Monthly 1% Premium Index(NTR) (KUSQL500P)
5/4/2026, 12:00:00 AM
Vertex Pharmaceuticals is scheduled to report its first quarter 2026 financial results after the market closes on May 4, 2026; earnings reports often cause 5% or more price movement, scheduled.
Korean Translation
버텍스 파마슈티컬스는 2026년 5월 4일 장 마감 후 2026년 1분기 재무 실적을 발표할 예정이며, 실적 발표는 통상 5% 이상의 주가 변동을 수반할 것으로 예정됨.
Related Recent Events
Bristol-Myers Squibb Co (BMY) · Other
The U.S. Food and Drug Administration (FDA) has set a Prescription Drug User Fee Act (PDUFA) target action date of August 17, 2026, for its decision on iberdomide for relapsed or refractory multiple myeloma, scheduled. Low impact estimated as the target date is a procedural milestone.
8/17/2026, 12:00:00 AM
Blackstone Inc (BX) · Earnings Release
Blackstone is scheduled to release its Q2 2026 earnings results, with analysts forecasting earnings of approximately $1.34-$1.36 per share, scheduled.
7/23/2026, 12:00:00 AM
Union Pacific Corp (UNP) · Earnings Release
Q2 2026 earnings release is scheduled. Low impact estimated as the date announcement is a routine event; scheduled.
7/23/2026, 12:00:00 AM
Goldman Sachs Group Inc (The) (GS) · Earnings Release
Goldman Sachs' Q2 2026 earnings release is scheduled.
7/14/2026, 12:00:00 AM
NIKE Inc (NKE) · Earnings Release
Q4 Fiscal Year 2026 earnings release is scheduled for June 25, 2026. Low importance as the announcement of the date typically has a minimal market impact.
6/25/2026, 12:00:00 AM
Vistra Corp (VST) · Other
Quarterly dividend of $0.2290 per share with an ex-dividend date of June 22, 2026; low importance estimated as dividends usually cause minor price adjustments, scheduled.
6/22/2026, 12:00:00 AM